Table 3.
Utilisation of selected atypical antipsychotics in Austria as a percentage of total atypical antipsychotic use between 2005 and 2010 (defined daily dose basis)
| Atypical antipsychotic | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | % Change |
|---|---|---|---|---|---|---|---|
| Risperidone |
31.6 |
29.9 |
28.6 |
26.9 |
25.5 |
23.8 |
-25 |
| Amisulpride |
8.4 |
7.1 |
6.7 |
6.3 |
5.9 |
5.5 |
-35 |
| Aripiprazole |
2.5 |
5.4 |
7.2 |
9.1 |
10.6 |
11.8 |
376 |
| Olanzapine |
36.6 |
33.3 |
31.3 |
29.6 |
28.0 |
26.1 |
-29 |
| Quetiapine |
18.6 |
22.5 |
24.8 |
27.0 |
29.6 |
32.7 |
75 |
| Paliperidone |
0.00 |
0.00 |
0.00 |
0.02 |
0.04 |
0.03 |
NA |
| Zotepine | 2.2 | 1.8 | 1.4 | 0.9 | 0.4 | 0.1 |
NA, not applicable.